US Patent 9901623 Rapid-acting insulin compositions
Patent 9901623 was granted and assigned to Eli Lilly and Company on February, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9901623 Rapid-acting insulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
